^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
sirolimus for injection (albumin-bound) (SRL-HSA)
i
Other names: SRL-HSA
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
CSPC Pharma
Drug class:
mTOR inhibitor
Related drugs:
3ms
Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors (clinicaltrials.gov)
P2/3, N=243, Recruiting, CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
New P2/3 trial
|
everolimus • sirolimus • sirolimus for injection (albumin-bound) (SRL-HSA)
7ms
Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard Therapy (clinicaltrials.gov)
P2, N=78, Active, not recruiting, CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
New P2 trial
|
fulvestrant • letrozole • anastrozole • sirolimus • exemestane • sirolimus for injection (albumin-bound) (SRL-HSA)
8ms
Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors (clinicaltrials.gov)
P3, N=312, Not yet recruiting, CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
New P3 trial
|
fulvestrant • sirolimus • sirolimus for injection (albumin-bound) (SRL-HSA)
over3years
A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors (clinicaltrials.gov)
P1, N=270, Not yet recruiting, CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
New P1 trial
|
TSC2 (TSC complex subunit 2) • TSC1 (TSC complex subunit 1)
|
sirolimus • sirolimus for injection (albumin-bound) (SRL-HSA)
Share via
